|  Help  |  About  |  Contact Us

Publication : The viral latency-associated nuclear antigen augments the B-cell response to antigen in vivo.

First Author  Sin SH Year  2010
Journal  J Virol Volume  84
Issue  20 Pages  10653-60
PubMed ID  20686032 Mgi Jnum  J:164589
Mgi Id  MGI:4834703 Doi  10.1128/JVI.00848-10
Citation  Sin SH, et al. (2010) The viral latency-associated nuclear antigen augments the B-cell response to antigen in vivo. J Virol 84(20):10653-60
abstractText  Gammaherpesviruses, including Kaposi sarcoma-associated herpesvirus (KSHV), establish latency in B cells. We hypothesized that the KSHV latency-associated nuclear antigen (LANA/orf73) provides a selective advantage to infected B cells by driving proliferation in response to antigen. To test this, we used LANA B-cell transgenic mice. Eight days after immunization with antigen without adjuvant, LANA mice had significantly more activated germinal center (GC) B cells (CD19(+) PNA(+) CD71(+)) than controls. This was dependent upon B-cell receptor since LANA did not restore the GC defect of CD19 knockout mice. However, LANA was able to restore the marginal zone defect in CD19 knockout mice.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

Trail: Publication

0 Expression